A unifying feature of many proteins associated with ALS, including TDP-43 and ataxin-2, is that they localize to stress granules. Unexpectedly, we found that genes that modulate stress granules are strong modifiers of TDP-43 toxicity in Saccharomyces cerevisiae and Drosophila melanogaster. eIF2a phosphorylation is upregulated by TDP-43 toxicity in flies, and TDP-43 interacts with a central stress granule component, polyA-binding protein (PABP). In human ALS spinal cord neurons, PABP accumulates abnormally, suggesting that prolonged stress granule dysfunction may contribute to pathogenesis. We investigated the efficacy of a small molecule inhibitor of eIF2a phosphorylation in ALS models. Treatment with this inhibitor mitigated TDP-43 toxicity in flies and mammalian neurons. These findings indicate that the dysfunction induced by prolonged stress granule formation might contribute directly to ALS and that compounds that mitigate this process may represent a novel therapeutic approach. 1 5 3 that decreases eIF2α phosphorylation may provide a promising avenue for therapeutic intervention in disease.
ALS is an intractable neurodegenerative disease that affects upper and lower motor neurons, resulting in debilitating and lethal paralysis 1, 2 . There is no cure and only one effective treatment, riluzole, which extends life by only 3 months on average. Thus, novel therapeutic strategies are desperately needed. The genetic underpinnings of sporadic and familial ALS are heterogeneous and have been incompletely characterized, but almost all cases of ALS share a pathological endpoint: the accumulation of ubiquitin-positive cytoplasmic inclusions that contain the RNA-binding protein TDP- 43 (ref. 3) . The focus on TDP-43 and other RNA-binding proteins has intensified as mutations affecting members of an expanding family of RNA recognition motif (RRM)-containing proteins with prion-like domains-FUS/TLS, TAF15, EWSR1, hnRNPA2B1 and hnRNPA1-have been found in individuals with ALS [4] [5] [6] [7] . Efforts to identify the molecular functions of TDP-43 that may be relevant to its role in proteinopathy have elucidated several RNA-processing functions 8 , including a possible role in the formation and regulation of the RNA granules that form under stress conditions [9] [10] [11] .
When primary neurons and cultured cells are stressed, TDP-43 translocates from the nucleus to cytoplasmic stress granules 11, 12 . Stress granules are thought to be protective during cellular stress, harboring translationally arrested polyadenylated mRNA, PABP, 40S ribosomal subunits and eukaryotic initiation factors 13 . The importance of the nucleus-to-cytosol trafficking of TDP-43 in stressed cells is not yet clear. The parallels between these observations in cells and the cytoplasmic mislocalization of TDP-43 and inclusion formation in patient spinal cord tissue has raised the possibility that stress granule formation may represent sites of early protein aggregation in ALS [14] [15] [16] [17] . Prolonged stress granule activity is predicted to lead to a prolonged stressed state and translational repression, which would be deleterious 15, [18] [19] [20] . In prion disease models, sustained translational repression by eIF2α phosphorylation mediates neurodegeneration 21, 22 .
To define toxic features of TDP-43 that may be relevant to human disease, we used yeast and Drosophila models coupled with the analysis of tissues from humans with ALS. Yeast and flies have proven to be powerful model systems for providing mechanistic insight into several neurodegenerative diseases, including ALS, Parkinson disease, Huntington disease and Alzheimer's disease [23] [24] [25] [26] [27] [28] . High-throughput screens in yeast, coupled with functional testing in the Drosophila nervous system, have been highly successful in identifying modifiers of disease-causing genes with findings that extend to human conditions 5, 25 . Here our genome-wide yeast screen identified genes involved in RNA metabolism, including several RNA-binding proteins with connections to stress granules, as critical in TDP-43 toxicity. Pursuing these genes, we unexpectedly found that eIF2α phosphorylation, indicative of stress granules and translational repression, becomes abnormally upregulated during TDP-43-associated neurodegeneration in Drosophila, and key genes that modulate eIF2α phosphorylation dramatically affect the ability of TDP-43 to be neurotoxic. We pursued these studies to identify a role for PABP, extending these studies to show that a small molecule Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models polyA-binding protein. Additionally, a previously uncharacterized yeast gene, YGR054W, was identified as interacting physically and genetically with several of the TDP-43 modifier genes (Fig. 1d) ; YGR054W encodes the yeast homolog of a translation initiation factor, EIF2A 38 . This network analysis and the additional interactors predicted by it helped us to focus our further analyses on PAB1 and translation initiation factors.
Given these findings, we then asked whether TDP-43 colocalized with the stress granule marker PUB1. These studies showed that TDP-43 accumulations in yeast colocalize with PUB1 ( Fig. 1e) A r t i c l e s npg A r t i c l e s and P-body markers have been found to colocalize with TDP-43 aggregates in samples from patients with ALS and in multiple models of disease 10, 39 . The results of our unbiased genetic screen indicate that stress granule components and the stressed state induced by such components may have a direct role in TDP-43 toxicity, as modifying their expression affects TDP-43 toxicity. Thus, not only are RNA granules markers of TDP-43 pathology in disease, but they may also have a more direct role in neurodegenerative disease pathogenesis.
Stress granule genes modulate TDP-43 toxicity in flies
To test the importance of the interaction between stress granules and ALS-associated RNA-binding protein toxicity in the nervous system, we used a Drosophila model. Although it is challenging to image stress granules in vivo in flies, eIF2α phosphorylation induces the accumulation of non-functional translation initiation complexes that concentrate in stress granules; thus, levels of eIF2α phosphorylation are directly correlated with the amount of stress granules 13 . We extracted protein from the heads of control and TDP-43-expressing flies and immunoblotted extracts with a phospho-specific antibody to eIF2α (Ser51). This approach showed a progressive increase in eIF2α phosphorylation upon expression of TDP-43 in the brain-there was no difference between control and TDP-43-expressing flies in the levels of eIF2α phosphorylation after 5 d of expression, but, by 8 d and 14 d, the levels of eIF2α phosphorylation were significantly increased to 1.4 ± 0.1-fold (s.e.m.) and 1.6 ± 0.1-fold (s.e.m.) relative to control flies, respectively ( Fig. 2a ). We did not observe an increase in the levels of eIF2α protein, showing that the change in the levels of phosphorylated eIF2α represents a change in the stress granule-specific form of the protein (Supplementary Fig. 1 ). These data suggest that TDP-43 expression in the fly brain induces chronic eIF2α phosphorylation. Moreover, the increase in eIF2α phosphorylation indicates a state of prolonged translational repression 22 .
To determine whether modulation of eIF2α phosphorylation could have an effect on TDP-43-associated neurodegeneration, we examined whether altering the levels of key genes that affect eIF2α phosphorylation could modulate TDP-43 toxicity in vivo. We knocked down the levels of PEK, Rox8 and Gadd34 by RNA interference (RNAi) in the presence of TDP-43 and examined the progressive effects on TDP-43-induced climbing dysfunction. PEK is the homolog of mammalian PERK and is a kinase that phosphorylates eIF2α, Rox8 is the Drosophila homolog of TIA1 that facilitates the physical aggregation of stress granules and Gadd34 is a phosphatase for eIF2α (refs. 40-43) . In mammalian cell lines, loss of PERK blocks calcium-induced stress granule formation, stimulation of eIF2α phosphorylation is necessary and sufficient for stress granule induction 44 , expression of dominant-negative TIA1 prevents stress granule formation 45 and treatment with GADD34 inhibitor induces massive stress granule formation 46 . Thus, reduction in PEK and Rox8 levels is predicted to inhibit, whereas knockdown of Gadd34 should enhance, stress granule formation in Drosophila. RNA , with the relative frequency of genes from the TDP-43 overexpression screen compared to the yeast genome and to the FUS overexpression screen 33 . Both the TDP-43 and FUS screens were enriched for RNA metabolic process genes, whereas the TDP-43 screen was enriched for cell cycle, transport and protein-modification process genes. (b) Although the TDP-43 and FUS screens were both enriched for RNA metabolic process genes, most of the hits did not overlap, with the exception of three genes. (c) Stress granule genes identified in the screen enhance or suppress TDP-43 toxicity. Spotting assay showing that, on the galactose plate (expression on), the coexpression of HRP1, KEM1 or PBP1 with TDP-43 leads to enhanced toxicity (reduced growth; red), whereas coexpression of TIS11 or VTS1 with TDP-43 leads to the suppression of toxicity (increased growth; green). (d) RNA-binding protein-focused yeast interaction network for TDP-43 screen hits identifies connections to PAB1 and the EIF2A homolog. Ten of 40 yeast genes that modified TDP-43 toxicity when overexpressed are annotated as encoding RNA-binding proteins. These are displayed as black circles. GeneMANIA 56 was used to search for interacting genes on the basis of physical and genetic interactions. Interacting genes are shown as gray circles, and network edges are colored according to the type of interaction. This analysis showed strong connections to PAB1 and YGR054W, which are highlighted in blue. YGR054W encodes the yeast homolog of a human translation initiation factor, EIF2A. (e) GFP-tagged ALS-linked TDP-43 forms aggregates when expressed in yeast and colocalizes with the stress granule marker PUB1-mCherry. Scale bar, 5 µm.
Flies expressing TDP-43 showed markedly reduced climbing ability compared to normal flies aged to 14 d (28 ± 5% (95% confidence interval, CI) compared to 82 ± 5% in controls; Fig. 2b ). This climbing deficit was greatly suppressed by knockdown of either Rox8 or PEK, with 62 ± 6% (95% CI) of flies retaining climbing ability compared to young flies; conversely, knockdown of Gadd34 led TDP-43-expressing flies to almost entirely lose their motility ( Fig. 2b) . Notably, we confirmed that downregulation of PEK decreased eIF2α phosphorylation and that downregulation of Gadd34 increased eIF2α phosphorylation ( Fig. 2c) . Knockdown of Gadd34, PEK or Rox8 individually had no effect on climbing ability (data not shown). Intriguingly, Gadd34 reduction, which enhanced TDP-43 toxicity in our locomotion assay, also led to the accumulation of TDP-43 protein in the cytoplasm (Fig. 2d) . Taken together, these data indicate that TDP-43-induced neural toxicity can be dramatically enhanced and suppressed by altering the expression of genes that converge on eIF2α phosphorylation.
The TDP-43-ataxin-2 interaction requires the PAM2 motif
To provide more insight into this potentially critical role of stress granules in TDP-43 toxicity, we investigated in greater detail the interaction between ataxin-2 and TDP-43. Ataxin-2, like TDP-43, localizes to stress granules and regulates their assembly and functions 47, 48 . PolyQ expansions in ataxin-2 are a risk for ALS, and the ataxin-2 protein has several functional motifs, including one for the key stress granule protein PABP 49 . We generated transgenic fly lines that expressed human ataxin-2 with a normal-length polyQ repeat (ATXN2-22Q) or an expanded repeat within the range associated with ALS risk (ATXN2-32Q). As with Drosophila ataxin-2 (ref. 25 ), coexpression of either human protein with TDP-43 dramatically enhanced toxicity, with faster loss of lifespan and climbing ability ( Supplementary Fig. 2) . Intriguingly, ATXN2-32Q enhanced the toxicity of TDP-43 measured by lifespan more significantly than ATXN2-22Q, demonstrating that an expansion of only ten glutamine repeats relative to the normal protein, which places it in the ALSassociated range, has a significant effect in vivo.
Ataxin-2 has two key domains implicated in RNA binding function ( Fig. 3a) : the Lsm (like Sm) domain is important for RNA binding affinity 50 , whereas the PAM2 motif mediates interaction with PABP 51 . We generated domain-deletion forms of ATXN2-32Q and selected transgenic lines that expressed these proteins at the same levels as intact ATXN2-32Q. Expression of the deletion-bearing ATXN2-32Q proteins alone showed effects comparable to the intact ATXN2-32Q 
npg
A r t i c l e s protein-a mild disruption of retinal structure and slightly reduced lifespan (Supplementary Fig. 3) . We then assessed the ability of these forms to enhance the toxicity of TDP-43. Strikingly, whereas the ATXN2-Q32-∆LSM protein acted the same as ATXN2-Q32, the ATXN2-32Q-∆PAM2 protein completely lost the ability to interact with TDP-43 in retinal toxicity (Fig. 3b) . These results were similar for lifespan and climbing ability, with the ATXN2-32Q-∆PAM2 form showing almost complete loss of interaction with TDP-43 ( Fig. 3c,d) . Accumulation of TDP-43 protein was also unaffected by ATXN2-32Q-∆PAM2 (Fig. 3e) , consistent with functional loss of the interaction. This finding raised the possibility that PABP, which binds the PAM2 motif, might have a role in TDP-43-induced neurodegeneration and that the shared interaction of TDP-43 and ataxin-2 with PABP might represent a critical axis in stress granule formation and the biological effects of such stress.
PABP modulates TDP-43 toxicity in Drosophila
To investigate the potential role of PABP in ALS-associated gene toxicity, we examined the effects of the Drosophila gene dPABP (encoding the Drosophila homolog of the cytoplasmic protein PABPC1) on toxicity from TDP-43 and ATXN2. Whereas upregulation of dPABP on its own had minimal effects, coexpression with either TDP-43 or ATXN2-32Q enhanced toxicity, resulting in more severe retinal degeneration (Fig. 4a) . Consistent with a role for dPABP in conveying toxicity due to the interaction of TDP-43 and ATXN2, dPABP did not modulate ATXN2-32Q-∆PAM2 (Fig. 4a) . The effect of dPABP on TDP-43 was exquisitely dose dependent: reduction of endogenous levels using RNAi significantly delayed the progressive loss of motility that occurred upon expression of TDP-43 in the nervous system (Fig. 4b) . dPABP downregulation did not affect total TDP-43 protein levels in the brain but did cause a reduction by 0.7 ± 0. npg the cytoplasmic levels of TDP-43 compared to the TDP-43 levels with normal dPABP levels (Fig. 4c) . Consistent with the essential function of the RNA-binding activity of TDP-43, expression of TDP-43 with point mutations affecting the aromatic residues of the RRMs 25,52 did not induce neurodegeneration or synergize with ATXN2 or dPABP (Supplementary Fig. 4 ). We confirmed that dPABP had no effect on the efficiency of the GAL4/UAS driver system ( Supplementary  Fig. 5 ). These data indicate that interactions with PABP modulate TDP-43 toxicity, suggesting that PABP function may be critical in human disease.
PABPC1 is mislocalized in spinal cord motor neurons in ALS
To determine whether PABP function might be altered in human disease, we immunostained spinal cord tissues from control individuals and ones with ALS for PABPC1 protein-cytoplasmic PABP-to examine whether there were pathological associations between PABPC1 localization and ALS. In control spinal cord neurons, PABPC1 showed a diffuse cytoplasmic localization pattern in most neurons (Fig. 5a) , occasionally being present in denser accumulations (2 ± 0.7% (s.e.m.) of motor neurons; Fig. 5b,e ). In spinal cord tissues from individuals with ALS, robust cytoplasmic inclusions of PABPC1 were observed in 13 ± 4% (s.e.m.) of motor neurons (Fig. 5c-e and Supplementary Table 1 ). Recent analysis of the colocalization of pathologically phosphorylated TDP-43 with PABPC1 indicated ~70% overlap in ALS human tissues 10 . These data suggest that interactions with or altered function of PABPC1 might occur in ALS and that the punctate accumulations containing PABPC1 in ALS spinal cords might represent structures with a functional role similar to that of stress granules and be indicative of a prolonged stress state and associated altered signaling pathways. 
A r t i c l e s
Taken together, these findings raised the possibility that treatment approaches that alter the activities that affect stress granules and their contingent effects on translation and signaling pathways might affect ALS disease progression.
Pharmacological rescue of TDP-43 toxicity
To test the idea that targeting eIF2α phosphorylation in a therapeutic manner might modulate TDP-43 toxicity in the nervous system, we turned back to the fly. Our data with gene manipulation indicated that inhibition of PEK activity might be effective in mitigating TDP-43 toxicity. Compounds that inhibit PERK, the human homolog of PEK, have been developed. We therefore tested whether treating flies with the PERK inhibitor compound GSK2606414 (ref. 53 ) could affect TDP-43-associated neurodegeneration. Flies fed 10 µM GSK2606414 showed a markedly reduced level of eIF2α phosphorylation, 63 ± 3% (s.e.m.) of the levels detected in the heads of TDP-43-expressing flies (Fig. 6a) . Remarkably, with this level of inhibition, there was a dramatic mitigation of TDP-43-induced climbing dysfunction: whereas, normally at day 12, TDP-43-expressing flies had only 18 ± 5% (95% CI) climbing ability of control flies, with inhibitor treatment, they retained 42 ± 7% (95% CI) of normal climbing ability (Fig. 6b) .
To extend these studies to mammalian neurons, we assessed the ability of the PERK inhibitor to mitigate the toxicity of TDP-43 in primary neurons. Rat primary cortical neurons were transfected with two constructs-one expressing mApple and the other expressing either enhanced green fluorescent protein (EGFP) alone or EGFPtagged TDP-43. We imaged ~800-1,000 individual neurons from each condition at 24-h intervals for 7 d using automated microscopy 54 . Death of neurons was scored by the loss of detectable cell body mApple fluorescence. Previous studies have shown that the upregulation of TDP-43 is toxic to neurons, inducing degeneration, cytoplasmic mislocalization of TDP-43 and aggregation of the protein 55 , thus reflecting fundamental features of pathological TDP-43 associated with disease. To assess the ability of GSK2606414 to mitigate TDP-43 toxicity, we first performed a dose-response curve for the compound, testing a range of concentrations (100 nM, 250 nM, 500 nM, 1 µM, 2 µM and 5 µM). Concentrations of 1 µM or higher were deleterious on their own, but the nanomolar concentrations were tolerated (Fig. 6c-e and Supplementary  Table 2 ). We thus assessed the effect of the compound on TDP-43 toxicity with concentrations of 100, 250 and 500 nM. These studies showed that treatment of primary neurons with PERK inhibitor GSK2606414 mitigated TDP-43 toxicity at 250 and 500 nM concentrations (P < 0.01; Fig. 6c,e and Supplementary Table 2c ). Taken together, these data indicate that prolonged activity of eIF2α phosphorylation functionally affects TDP-43 toxicity and suggest the possibility that compounds that mitigate this activity, such as GSK2606414, could be developed as a therapeutic strategy for ALS and related TDP-43 proteinopathies.
DISCUSSION
A common biological feature of several RNA-binding proteins connected to neurodegenerative diseases is their localization to cytoplasmic stress granules, and a working hypothesis for disease is that stress granule formation facilitates or promotes TDP-43 aggregation in ALS 11, 15, [17] [18] [19] [20] 39 . Moreover, stress granule markers such as TIA1 and eIF3 colocalize with TDP-43 inclusions in ALS and the clinicopathologically related disorder frontotemporal lobular degeneration with ubiquitinated inclusions (FTLD-U) 16 . However, the relationship between these observations and neurotoxicity is not clear. These findings do suggest, however, that ALS may be associated with a prolonged stress state and the outcome of such a state. Thus, it has been npg unclear whether genes that affect stress granule formation directly affect TDP-43 neurotoxicity. The prolonged presence of stress granules would result in long-term translational repression and altered signaling pathways-sustained translational repression is thought to be causal in prion-mediated neurodegeneration, and reversing this repression has the ability to mitigate disease 21, 22 . Here we show that eIF2α phosphorylation is increased upon TDP-43-induced neural dysfunction in Drosophila, that genes that are implicated in stress granule formation affect TDP-43 toxicity in yeast and that TDP-43-induced climbing deficits in flies are modulated by knockdown of genes whose activity normally modulates eIF2α phosphorylation. Moreover, the interaction between ataxin-2 and TDP-43 is mediated through PABP in Drosophila, and PABPC1 is mislocalized in ALS. As a proof of principle that modulating eIF2α phosphorylation could be beneficial, a small molecule inhibitor of PERK activity significantly suppressed TDP-43 toxicity in vivo in the fly and mitigated TDP-43 toxicity in mammalian primary cortical neurons. Thus, inhibi tory activity of molecules on stress granule formation, and thus on a potentially prolonged stress state in disease, might accurately gauge potential therapeutic activity in vivo. Molecules that decrease stress granule formation or stability could represent a promising avenue for the treatment of ALS and other TDP-43 proteinopathies. Such compounds may affect TDP-43 accumulation and might also mitigate the outcome of prolonged stress that contributes to degeneration.
URLs. Saccharomyces Genome Database, http://www.yeastgenome. org/; VassarStats, http://www.vassarstats.net/.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METhODS
Yeast plasmid overexpression screen. The query strain was generated by integrating the TARPDP gene encoding TDP-43 into the HIS3 locus using a p303-GAL-TDP-43 vector 25 . Plasmids from the yeast FLEXgene collection (5,500 full-length yeast ORFs) were transformed into the query strain. The screen was performed similarly to previous screens 33 and as described 25, 31 . The screen was replicated three times, and only those hits that consistently reproduced were considered to be modifiers of TDP-43. A control strain with YFP (p303-GAL-YFP) integrated into the HIS3 locus was used in experiments to confirm that the overexpression strains did not exhibit toxicity or a growth advantage when TDP-43 was not expressed. GO term analysis of the hits was performed using the GO-slim mapper tool available at the Saccharomyces Genome Database website. GeneMANIA 56 was used to search for interacting genes on the basis of physical and genetic interactions.
Yeast transformation and spotting assays. PEG-lithium acetate yeast transformations and spotting assays were performed according to standard protocols.
Visualizing stress granules in yeast.
A plasmid expressing PUB1-mCherry, a stress granule marker 57 , was transformed into the wild-type yeast strain BY4741. Subsequently, p415-GAL-GFP or p415-GAL-TDP-43-GFP plasmids were transformed into the strain. The TDP-43 expression plasmid was created using an LR reaction with the destination vector p415-GAL-ccdB-GFP and the donor vector pDONR221-TDP-43 (Center for Cancer Systems Biology Human ORFeome Collection). Transformants were grown overnight in raffinose-containing selective medium (CSM-Ura-Leu) and then added to galactose-containing selective medium and allowed to grow for 6 h to induce the expression of the galactoseinducible genes. Yeast were mounted in the medium they were grown in on coverslips coated with concanavalin A (Sigma, L7647) 58 . Images were captured on a Leica DM6000B with a ProEM EMCCD camera (Princeton Instruments).
Drosophila strains. Drosophila stocks were maintained on standard cornmeal agar medium at 25 °C unless otherwise noted. elav 3A -GAL4 was a gift from M.A. Tanouye 59 . UAS-TDP-43 was described previously 25 . The Bloomington stock center provided other fly stocks.
DNA constructs for germline transformation.
In generating randominsertion transgenic lines, we used the pUAST vector 60 . Human ATXN2 cDNA that has 32 CAG repeats was cloned into the pUAST vector as a BglII-XbaI fragment. The pUAST-ATXN2-Q32-∆PAM2 construct was generated by deleting the region encoding amino acids 910-922 of the PAM2 domain. The pUAST-ATXN2-32Q construct encoding the full-length ATXN2 protein with 32Q repeats was used as a template for two PCR runs. The sequence upstream of the region encoding the PAM2 domain was amplified using a forward primer containing an attached BglII cut site, primer PAM2-N1 (primer sequences listed in Supplementary Table 3) , and a reverse primer complementary to the sequence encoding the beginning of the PAM2 domain and containing an attached HindIII cut site, primer PAM2-N2. The sequence upstream of the region encoding the PAM2 domain was amplified using a forward primer complementary to the region encoding the end of the PAM2 domain and containing an attached HindIII cut site, primer PAM2-C1, and a reverse primer containing an attached XbaI cut site, primer PAM2-C2. Each PCR product was subcloned into TOPO vectors, cloned into pUAST vectors, cut out of the pUAST vector, ligated together and reinserted into a pUAST vector.
Similarly, the pUAST-ATXN2-Q32-∆LSM construct was generated by deleting the region encoding amino acids 267-325 of the PAM2 domain. The pUAST-ATXN2-Q32 construct was used as a template for two PCR runs. The sequence upstream of the region encoding the LSM domain was amplified using a forward primer containing an attached BglII cut site, primer LSM-N1, and a reverse primer complementary to the sequence corresponding to the beginning of the LSM domain and containing an attached HindIII cut site, primer LSM-N2. The sequence encoding downstream of the region encoding the LSM domain was amplified using a forward primer complementary to the region encoding the end of the LSM domain and containing an attached HindIII cut site, primer LSM-C1, and a reverse primer containing an attached XbaI cut site primer, LSM-C2. Each PCR product was subcloned into TOPO vectors, cloned into pUAST vectors, cut out of the pUAST vector, ligated together and reinserted into a pUAST vector.
For generation of site-specific integration transgenic lines, we used pJFRC5 and pJFRC5-myc vectors 61 . ATXN2 cDNA with 32 or 22 CAG repeats was cloned into pJFRC5-myc vector as a SwaI-XbaI fragment. These DNA constructs were integrated into the attP2 landing site.
External eye and retinal tissue microscopy. For fly eye images, we used a Leica Z16-Apo A motorized zoom microscope system with DFC420 digital camera and Leica Application Suite Montage module software (Leica Microsystems). Retinal tissue was visualized by autofluorescence in horizontal paraffin sections. Males that were 0-1 d old were used for experiments.
Lifespan and adult climbing assays. Males that were 0-1 d old were separated and transferred into experimental vials containing fly medium mixed with or without RU486 (20 or 40 µg/ml) at a density of 20 (for lifespan assays) or 25 (for climbing assays) flies per vial. Dead flies were scored every day, and flies were transferred to fresh medium every other day. All flies for climbing assays or lifespan analysis were raised at 29 °C. Adult locomotor function was assessed by a previously described method, with 125 flies per genotype per time point in all experiments, except for Supplementary Figure 2d , where 150 flies per genotype per time point were used 62 . Experiments were repeated twice to assure consistent results.
Immunoblotting. For total protein extraction, ten male fly heads were homogenized in 1× LDS sample buffer (Invitrogen). For subcellular fractionation, 20 male fly heads were lysed in NE-PER extraction reagent (Pierce) according to the manufacturer's protocol. Extracts (equivalent to 2 heads/lane) were then run on 3-8% Tris-Acetate gels or 4-12% Bis-Tris gels (Invitrogen). Protein blotting was performed according to standard protocols. The following primary antibodies were used: antibody to TDP-43 (1:800 dilution; Proteintech, 10782-2-AP); antibody to β-actin (1:2,000 dilution; Abcam, ab16039); antibody to α-tubulin (1:2,000 dilution; conjugated with HRP, Cell Signaling Technology, 9099); antibody to lamin C (1:1,000 dilution; Developmental Studies Hybridoma Bank, LC28.26); antibody to phos phorylated eIF2α (1:1,000 dilution; Cell signaling Technology, 9722); antibody to mouse ataxin-2 (1:300 dilution; BD Biosciences, 6113378); antibody to rabbit eIF2α (1:1,000 dilution; Abcam, ab26197); and antibody to mouse β-galactosidase (1:1,000 dilution; Promega, Z3781). After incubation with HRP-coupled secondary antibodies (goat antibody to rabbit diluted 1:2,000 and goat antibody to mouse diluted 1:2,000; Pierce), blots were visualized using ECL plus or prime kit (Amersham Biosciences). Quantification of protein blots was performed using ImageGauge4.22 (GE Healthcare).
Immunohistochemistry of human post-mortem spinal cord. Human spinal cord tissue fixed in 10% neutral-buffered formalin was processed into paraffin. Tissue was sliced into 7-µm sections, and PABPC1 was immunostained with antigen retrieval (antigen-unmasking solution, citric acid based, Vector Laboratories, H-3300) and the avidin-biotin complex detection method with 3,3′-diaminobenzidine as the chromagen (Vectastain ABC detection kit, Vector Labs, PK-6100). Rabbit polyclonal antibody to PABPC1 was used at a 1:800 dilution (Cell Signaling Technology, 4992S). Biotinylated antibody to rabbit IgG (Vector Labs, BA-1000) was used at a 1:1,000 dilution. Stained sections were counterstained with hematoxylin and eosin.
Drug treatment. GSK2606414 (PERK inhibitor; EMD Millipore, 516535) was added directly to medium from a 1 mg/ml stock (dissolved in DMSO) to give a final concentration of 10 µM. The same amount of DMSO was added for vehicle control.
Statistical analyses. For climbing and immunoblot quantifications, data were analyzed by Student's t test (VassarStats) or first analyzed using oneway ANOVA followed by Tukey's multiple-comparisons test (GraphPad Prism Software). Human immunohistochemistry data were analyzed by one-tailed Mann-Whitney test (VassarStats). Differences were considered significant when P < 0.05 and are indicated as follows: *P < 0.05; **P < 0.01; ***P < 0.001; # P < 0.0001; NS, not significant. 
